Oxford BioMedica (OTCMKTS:OXBDF) Sets New 12-Month Low – Here’s What Happened

Shares of Oxford BioMedica (OTCMKTS:OXBDF) reached a new 52-week low on Wednesday . The stock traded as low as $5.80 and last traded at $5.9966, with a volume of 6505 shares traded. The stock had previously closed at $5.89.

Analyst Upgrades and Downgrades

Separately, Zacks Research raised Oxford BioMedica to a “hold” rating in a research report on Wednesday, July 22nd. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the company presently has an average rating of “Hold”.

Oxford BioMedica Price Performance

The stock’s 50 day simple moving average is $7.29 and its two-hundred day simple moving average is $7.82.

About Oxford BioMedica

Oxford BioMedica plc is a United Kingdom-based contract development and manufacturing organization (CDMO) focused on cell and gene therapies. The company helps biotechnology and pharmaceutical customers develop, test, and manufacture advanced therapies, with expertise in viral-vector technologies used to deliver genetic material into cells.

Its services include process and analytical development, clinical and commercial manufacturing, quality testing, regulatory support, and related research services.